The DOI matches its Crossref record; 355 of the 355 references it cites were found in a registry or an index.
Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy
Open accessAbstract
The Wnt/β-catenin signaling pathway plays a crucial role in various physiological processes, encompassing development, tissue homeostasis, and cell proliferation. Under normal physiological conditions, the Wnt/β-catenin signaling pathway is meticulously regulated. However, aberrant activation of this pathway and downstream target genes can occur due to mutations in key components of the Wnt/β-catenin pathway, epigenetic modifications, and crosstalk with other signaling pathways. Consequently, these dysregulations contribute significantly to tumor initiation and progression. Therapies targeting the Wnt/β-catenin signaling transduction have exhibited promising prospects and potential for tumor treatment. An increasing number of medications targeting this pathway are continuously being developed and validated. This comprehensive review aims to summarize the latest advances in our understanding of the role played by the Wnt/β-catenin signaling pathway in carcinogenesis and targeted therapy, providing valuable insights into acknowledging current opportunities and challenges associated with targeting this signaling pathway in cancer research and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Wnt/β-catenin pathway is a well-established oncogenic driver in numerous cancers, including ccRCC, where its aberrant activation is linked to tumor initiation and progression [30–32].”
From PPP1R18-mediated activation of Wnt/β-catenin and EMT is dependent on ERK signaling in clear cell renal cell carcinoma (2026) · cites this paper as [31]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wu, L., He, S., He, Y., Wang, X., & Lu, L. (2018) · Medical Science Monitor · doi:10.12659/msm.910742 · Cited by 14 · cited 1×
“IC-2, a small molecule inhibitor, effectively diminishes the population of CD44 cells (liver CSCs) and impedes sphere-forming capacity in HCC, CRC, and bladder cancer cells [343–345].”
BackgroundRetractedComprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499 · cited 1×
“The Wnt signaling pathway alterations are universally observed in CRC tissues, with more than 90% of CRC cases harboring mutations in genes such as APC, CTNNB1, RNF42, AXIN1, or RSPO [196].”
BackgroundIdentification of stem cells in small intestine and colon by marker gene Lgr5
Barker, N., van Es, J. H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M., Haegebarth, A., Korving, J., Begthel, H., Peters, P. J., et al. (2007) · Nature · doi:10.1038/nature06196 · Cited by 5,687 · cited 1×
“Several characteristics have been identified in stem cells, including Lgr5, Bmi1, Lrig1 and Dclk1 [205–207].”
BackgroundWnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Nusse, R., & Clevers, H. (2017) · Cell · doi:10.1016/j.cell.2017.05.016 · Cited by 4,342
Integrative Clinical Genomics of Advanced Prostate Cancer
Robinson, D., Van Allen, E. M., Wu, Y.-M., Schultz, N., Lonigro, R. J., Mosquera, J.-M., Montgomery, B., Taplin, M.-E., Pritchard, C. C., Attard, G., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.001 · Cited by 3,645 · cited 1×
“…that activation of Wnt/β-catenin signaling due to genetic changes occurs more frequently in castration-resistant prostate cancer (CRPC) compared to treatment-naïve cases, as evidenced by clinical samples obtained from CRPC patients, which demonstrate alterations in CTNNB1 and APC genes [237].”
BackgroundWnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
Liu, J., Xiao, Q., Xiao, J., Niu, C., Li, Y., Zhang, X., Zhou, Z., Shu, G., & Yin, G. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00762-6 · Cited by 2,519 · cited 1×
“…chloroquine is an FDA-approved drug commonly utilized for treating tapeworm infection and stands out due to its mechanism involving internalization of the FZD1 receptor, reduction in DVL2 protein levels, and targeting of LRP6 to impede tumor proliferation, stemness, and metastasis [356, 357].”
BackgroundTankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037 · cited 1×
“Several TNKS inhibitors with favorable therapeutic effects have been developed, including XAV939, G007LK, G244-LM, RK-287,107, JW55, K-756, IWR-1, MSC2504877, AZ1366, JW74, and NVP-TNKS656 [308–317].”
BackgroundWNT signalling pathways as therapeutic targets in cancer
Anastas, J. N., & Moon, R. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3419 · Cited by 1,911 · cited 1×
“The downstream effector in this cascade is β-catenin which serves as a vital component of the canonical Wnt pathway [25].”
BackgroundNusse, R., & Varmus, H. E. (1982) · Cell · doi:10.1016/0092-8674(82)90409-3 · Cited by 1,863 · cited 1×
“The Wnt gene is synonymous with the Drosophila segment polarity gene Wingless and the murine proto-onco-gene integration 1, which was molecularly characterized from mouse tumor cells in 1982 [14].”
BackgroundThe many faces and functions of β‐catenin
Valenta, T., Hausmann, G., & Basler, K. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.150 · Cited by 1,598
Research works printed but not linked: 6
- Nusse R, Clevers H. Wnt/beta-Catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169(6):985–99. · DOI · Paper page
- Cai J, Fang L, Huang Y, Li R, Xu X, Hu Z, et al. Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by mir-128-3p confers chemoresistance-associated metastasis in NSCLC. Nat Commun. 2017;8:15870. · DOI · Paper page
- Chai S, Ng KY, Tong M, Lau EY, Lee TK, Chan KW, et al. Octamer 4/microRNA-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells. Hepatology. 2016;64(6):2062–76. · DOI · Paper page
- Wang Z, Li Z, Ji H. Direct targeting of β-catenin in the wnt signaling pathway: current progress and perspectives. Med Res Rev. 2021;41(4):2109–29. · DOI
- Jung YS, Park JI. Wnt signaling in cancer: therapeutic targeting of wnt signaling beyond β-catenin and the destruction complex. Exp Mol Med. 2020;52(2):183–91. · DOI · Paper page
- Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M, et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol Cancer. 2022;21(1):144. · DOI · Paper page
Cited by
Helicobacter pylori and gastric cancer: mechanisms and new perspectives
Duan, Y., Xu, Y., Dou, Y., & Xu, D. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01654-2 · Cited by 300
Cancer stem cells: landscape, challenges and emerging therapeutic innovations
Lee, H., Kim, B., Park, J., Park, S., Yoo, G., Yum, S., Kang, W., Lee, J.-M., Youn, H., & Youn, B. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02360-2 · Cited by 188
Yu, B., & Ma, W. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.08.006 · Cited by 121
Cell migration in diabetic wound healing: Molecular mechanisms and therapeutic strategies (Review)
Song, J., Zhao, T., Wang, C., Sun, X., Sun, J., & Zhang, Z. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5567 · Cited by 116
“7) (146).”
Galasso, L., Termite, F., Mignini, I., Esposto, G., Borriello, R., Vitale, F., Nicoletti, A., Paratore, M., Ainora, M. E., Gasbarrini, A., et al. (2025) · Cancers · doi:10.3390/cancers17030368 · Cited by 91
“Activation of this pathway by F. nucleatum has been associated with poor outcomes in CRC patients due to its role in driving uncontrolled tumor growth and metastasis [23,24].”
Metadata
- Authors
- Song, P., Gao, Z., Bao, Y., Chen, L., Huang, Y., Liu, Y., Dong, Q., & Wei, X.
- Affiliations
- West China Hospital of Sichuan University (CN)
- Sichuan University (CN)
- Corresponding author
- Dong, Qiang
- Wei, Xiawei
- Venue
- Journal of Hematology & Oncology
- Published
- 2024-06-18
- Volume
- 17
- Issue
- 1
- Pages
- 46-46
- ISSN
- 1756-8722 (ISSN-L)
- PMC
- PMC11184729
- OpenAlex
- W4399792819
- Cited by
- 382
- References
- 354
- Citations by year
- 2026: 167 · 2025: 193 · 2024: 22
- FWCI
- 15.54
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Hematology & Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Science Foundation for Excellent Young Scholars (32122052)
- National Natural Science Foundation Regional Innovation and Development (No. U19A2003)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Wnt/β-catenin signaling, carcinogenesis, cancer therapy, targeted therapy, tumor initiation and progression, epigenetic modifications, signaling crosstalk, Wnt inhibitors, cell proliferation, tissue homeostasis
- MeSH terms
- Animals, Antineoplastic Agents, Humans, Neoplasms, beta Catenin, Molecular Targeted Therapy, Wnt Signaling Pathway, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy. https://app.cochat.ai/papers/10.1186/s13045-024-01563-4
- The paper
- Song, P., Gao, Z., Bao, Y., Chen, L., Huang, Y., Liu, Y., Dong, Q., & Wei, X. (2024). Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy. Journal of Hematology & Oncology. https://doi.org/10.1186/s13045-024-01563-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.